We are closely monitoring the unprecedented developments around the coronavirus disease (COVID-19) pandemic and its potential impact on employees and business operations.
We want to assure our clients that the daily operations at our lab have been minimally impacted.
Our industry has a unique responsibility to continue with research and development. Our goal is to mindfully modify operations as needed to ensure the safety of our employees while maintaining the delivery of products and services. Our lab is operational and we are able to provide flexible work arrangements that will prevent work stoppage if needed.
Our vendors have expressed that there are currently no known threats to supply. We have banked cells in reserve for use in current and future contracts, as well as products stocked in inventory for our customers placing product orders. Our lab has the capability to receive client compounds that are shipped for contract services and has the capacity to initiate new client studies. If these circumstances change, we will notify those whose studies would be directly influenced.
Our team will continue to meet to review the rapidly changing information from the Centers for Disease Control (CDC), World Health Organization, and our local health districts and will continue to communicate any changes affecting our operations.